Synedgen has announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop ...

A new generation of remote monitoring devices in Scotland is helping to reduce the burden on healthcare systems and improve ...

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief ...

In pharmaceutical manufacturing, viscous drug products pose unique challenges to filling efficiency and accuracy.

The agreement will see MEDiC’s MCAT platform identify biomarkers to support the development of Hanmi’s clinical assets.

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

Despite this setback, Transgene plans to explore the potential benefits of the vaccine in specific patient populations.

digital twins can be used to progress healthcare, drug development, and research by enabling the delivery of personalised ...

UroGen Pharma has received the NDA acceptance from the US FDA for UGN-102 (mitomycin) to treat bladder cancer.

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is set to grow from sales of $11.5bn in 2023 to $30.8bn in ...